Trial
NCT02472002
Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Coronary Disease
Intervention
Mesenchymal cell therapy
Why stopped
Contamination of the Pitié-Salpêtrière biotherapy laboratory
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-02-23